Researchers at the St. Jude Children’s Research Hospital and the Children’s Oncology Group have uncovered more than 100 genetic variations that appear to influence how pediatric patients with acute lymphoblastic leukemia metabolize chemotherapeutic agents.
Read the original here:
St. Jude’s Team Uncovers Gene Variants That May Influence Rx Metabolism in Pediatric ALL (GenomeWeb News)
0 responses so far ↓
There are no comments yet...Kick things off by filling out the form below.
You must log in to post a comment.